<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36337005</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0838</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Scandinavian journal of medicine &amp; science in sports</Title><ISOAbbreviation>Scand J Med Sci Sports</ISOAbbreviation></Journal><ArticleTitle>Short and mid-term characteristics of COVID-19 disease course in athletes: A high-volume, single-center study.</ArticleTitle><Pagination><StartPage>341</StartPage><EndPage>352</EndPage><MedlinePgn>341-352</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/sms.14265</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">At the pandemic's beginning, significant concern has risen about the prevalence of myocardial involvement after SARS-CoV-2 infection. We assessed the cardiovascular burden of SARS-CoV-2 in a large cohort of athletes and identified factors that might affect the disease course. We included 633 athletes in our study on whom we performed extensive cardiology examinations after recovering from SARS-CoV-2 infection. More than half of the athletes (n&#xa0;=&#xa0;322) returned for a follow-up examination median of 107&#x2009;days after the commencement of their infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Troponin T positivity was as low as 1.4% of the athletes, where the subsequently performed examinations did not show definitive, ongoing myocardial injury. Altogether, 31% of the athletes' rapid training rebuild was hindered by persistent or reoccurring symptoms. Female athletes reported a higher prevalence of return to play (RTP) symptoms than their male counterparts (34% vs. 19%, p&#xa0;=&#xa0;0.005). The development of long COVID symptoms was independently predicted by increasing age and acute symptoms' severity in a multiple regression model (AUC 0.75, CI 0.685-0.801). Athletes presenting with either or both cough and ferritin levels higher than &gt;150&#x2009;&#x3bc;g/L had a 4.1x (CI 1.78-9.6, p&#xa0;=&#xa0;0.001) higher odds ratio of developing persistent symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">While SARS-CoV-2 rarely affects the myocardium in athletes, about one in three of them experience symptoms beyond the acute phase. Identifying those athletes with a predisposition to developing long-standing symptoms may aid clinicians and trainers in finding the optimal return-to-play timing and training load rebuild pace.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Scandinavian Journal of Medicine &amp; Science In Sports published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Juh&#xe1;sz</LastName><ForeName>Vencel</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9100-4952</Identifier><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szab&#xf3;</LastName><ForeName>Lili&#xe1;na</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4699-3648</Identifier><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavlik</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Sports Medicine, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xe1;llay</LastName><ForeName>Andr&#xe1;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Sports Medicine, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balla</LastName><ForeName>Dorottya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiss</LastName><ForeName>Orsolya</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sports Medicine, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babity</LastName><ForeName>M&#xe1;t&#xe9;</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5334-5430</Identifier><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syd&#xf3;</LastName><ForeName>N&#xf3;ra</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sports Medicine, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csulak</LastName><ForeName>Emese</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bencz&#xfa;r</LastName><ForeName>Andr&#xe1;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Computer Science and Control, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orsz&#xe1;gh</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Computer Science and Control, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregor</LastName><ForeName>Zs&#xf3;fia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>D&#xe1;vid</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merkely</LastName><ForeName>B&#xe9;la</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sports Medicine, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;g&#xf3;</LastName><ForeName>Hajnalka</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3568-3572</Identifier><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sports Medicine, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020-4.1.1.-TKP2020</GrantID><Agency>Ministry for Innovation and Technology in Hungary, Thematic Excellence Programme</Agency><Country/></Grant><Grant><GrantID>NVKP_16-1-2016-0017</GrantID><Agency>National Research, Development, and Innovation Fund of Hungary</Agency><Country/></Grant><Grant><GrantID>RRF-2.3.1-21-2022-00004</GrantID><Agency>European Union</Agency><Country/></Grant><Grant><GrantID>2020-1.1.6-J&#xd6;V&#x150;-2021-00013</GrantID><Agency>National Research, Development and Innovation Office of Hungary</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Scand J Med Sci Sports</MedlineTA><NlmUniqueID>9111504</NlmUniqueID><ISSNLinking>0905-7188</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056352" MajorTopicYN="N">Athletes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">athletes</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID syndrome</Keyword><Keyword MajorTopicYN="N">return to play</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>7</Day><Hour>3</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36337005</ArticleId><ArticleId IdType="pmc">PMC9877648</ArticleId><ArticleId IdType="doi">10.1111/sms.14265</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Johns Hopkins University &amp; Medicine
. 2022. https://coronavirus.jhu.edu/map.html. Accessed March 10, 2022.</Citation></Reference><Reference><Citation>Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17&#x2010;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">33180902</ArticleId></ArticleIdList></Reference><Reference><Citation>
Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2010;mechanisms, risk factors, and management. BMJ [Internet]. 2021;374:n1648. http://www.ncbi.nlm.nih.gov/pubmed/34312178. Accessed October 12, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou HC. Post&#x2010;COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021;52:575&#x2010;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence (NICE) SIGN (SIGN) and RC of GP (RCGP)
. 2022. https://www.nice.org.uk/guidance/ng188/resources/covid19&#x2010;rapid&#x2010;guideline&#x2010;managing&#x2010;the&#x2010;longterm&#x2010;effects&#x2010;of&#x2010;covid19&#x2010;pdf&#x2010;51035515742. Accessed January 20, 2022.</Citation></Reference><Reference><Citation>Niebauer J, B&#xf6;rjesson M, Carre F, et al. Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2018;39(40):3664&#x2010;3671.</Citation><ArticleIdList><ArticleId IdType="pubmed">30165596</ArticleId></ArticleIdList></Reference><Reference><Citation>
NIH
. 2020. Clinical Spectrum of SARS&#x2010;CoV&#x2010;2 Infection [Internet]. https://www.covid19treatmentguidelines.nih.gov/overview/clinical&#x2010;spectrum/. Accessed October 12, 2021.</Citation></Reference><Reference><Citation>McKinney J, Velghe J, Fee J, Isserow S, Drezner JA. Defining athletes and exercisers. Am J Cardiol. 2019;123:532&#x2010;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">30503799</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27:601&#x2010;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS&#x2010;CoV&#x2010;2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2010;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira VM, Schulz&#x2010;Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158&#x2010;3176.</Citation><ArticleIdList><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID&#x2010;19). JAMA Cardiol. 2020;5(11):1265&#x2010;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID&#x2010;19 infection. JAMA Cardiol. 2021;6(1):116&#x2010;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito D, Meester S, Yanamala N, et al. High prevalence of pericardial involvement in college student athletes recovering from COVID&#x2010;19. JACC Cardiovasc Imaging. 2020;14(3):541&#x2010;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641597</ArticleId><ArticleId IdType="pubmed">33223496</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulson N, Petek BJ, Drezner JA, et al. SARS&#x2010;CoV&#x2010;2 cardiac involvement in young competitive athletes. Circulation [Internet]. 2021;144:256&#x2010;266. doi:10.1161/CIRCULATIONAHA.121.054824</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.054824</ArticleId><ArticleId IdType="pmc">PMC8300154</ArticleId><ArticleId IdType="pubmed">33866822</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavigli L, Cillis M, Mochi V, et al. SARS&#x2010;CoV&#x2010;2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed? Br J Sports Med. 2021;56(5):264&#x2010;270. doi:10.1136/bjsports-2021-104764</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2021-104764</ArticleId><ArticleId IdType="pubmed">34844952</ArticleId></ArticleIdList></Reference><Reference><Citation>Vago H, Szabo L, Dohy Z, Merkely B. Cardiac magnetic resonance findings in patients recovered from COVID&#x2010;19: initial experiences in elite athletes. JACC Cardiovasc Imaging. 2021;14(6):1279&#x2010;1281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837171</ArticleId><ArticleId IdType="pubmed">33341416</ArticleId></ArticleIdList></Reference><Reference><Citation>Szab&#xf3; L, Juh&#xe1;sz V, Dohy Z, et al. Is cardiac involvement prevalent in highly trained athletes after SARS&#x2010;CoV&#x2010;2 infection? A cardiac magnetic resonance study using sex&#x2010;matched and age&#x2010;matched controls. Br J Sports Med. 2021;56(10):553&#x2010;560. doi:10.1136/bjsports-2021-104576</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2021-104576</ArticleId><ArticleId IdType="pmc">PMC8637606</ArticleId><ArticleId IdType="pubmed">34848398</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez MW, Tucker AM, Bloom OJ, et al. Prevalence of inflammatory heart disease among professional athletes with prior COVID&#x2010;19 infection who received systematic return&#x2010;to&#x2010;play cardiac screening. JAMA. 2021;10019:1&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>
Fikenzer S, Kogel A, Pietsch C, et al. SARS&#x2010;CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players. Sci Rep. 2021;11(1):17798
https://www.nature.com/articles/s41598&#x2010;021&#x2010;97120&#x2010;x. Accessed December 6, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8423785</ArticleId><ArticleId IdType="pubmed">34493765</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervasi SF, Pengue L, Damato L, et al. Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS&#x2010;CoV&#x2010;2 infection? Br J Sports Med. 2021;55(1):54&#x2010;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536638</ArticleId><ArticleId IdType="pubmed">33020140</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID&#x2010;19 in the New York City area. JAMA. 2020;323(20):2052&#x2010;2059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltagliati S, Sieber S, Sarrazin P, et al. Muscle strength explains the protective effect of physical activity against COVID&#x2010;19 hospitalization among adults aged 50&#x2009;years and older. J Sports Sci. 2021;39(24):2796&#x2010;2803. doi:10.1080/02640414.2021.1964721</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02640414.2021.1964721</ArticleId><ArticleId IdType="pubmed">34376100</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham JW, Vaduganathan M, Claggett BL, et al. Clinical outcomes in young US adults hospitalized with COVID&#x2010;19. JAMA Intern Med. 2021;181:379&#x2010;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489373</ArticleId><ArticleId IdType="pubmed">32902580</ArticleId></ArticleIdList></Reference><Reference><Citation>Latorre&#x2010;Rom&#xe1;n P&#xc1;, Guzm&#xe1;n&#x2010;Guzm&#xe1;n IP, Delgado&#x2010;Floody P, et al. Protective role of physical activity patterns prior to COVID&#x2010;19 confinement with the severity/duration of respiratory pathologies consistent with COVID&#x2010;19 symptoms in Spanish populations. Res Sports Med. 2021;1&#x2010;12. doi:10.1080/15438627.2021.1937166</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15438627.2021.1937166</ArticleId><ArticleId IdType="pubmed">34128446</ArticleId></ArticleIdList></Reference><Reference><Citation>Brawner CA, Ehrman JK, Bole S, et al. Inverse relationship of maximal exercise capacity to hospitalization secondary to coronavirus disease 2019. Mayo Clin Proc. 2021;96(1):32&#x2010;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547590</ArticleId><ArticleId IdType="pubmed">33413833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasiakogias A, Sharma S. Exercise: the ultimate treatment to all ailments? Clin Cardiol. 2020;43:817&#x2010;826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403692</ArticleId><ArticleId IdType="pubmed">32506511</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez&#x2010;Valera M, Martinez&#x2010;Canton M, Gallego&#x2010;Selles A, et al. Angiotensin&#x2010;converting enzyme 2 (SARS&#x2010;CoV&#x2010;2 receptor) expression in human skeletal muscle. Scand J Med Sci Sports. 2021;31(12):2249&#x2010;2258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662278</ArticleId><ArticleId IdType="pubmed">34551157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l EK, Harbo T, Agergaard J, et al. Myopathy as a cause of fatigue in long&#x2010;term post&#x2010;COVID&#x2010;19 symptoms: evidence of skeletal muscle histopathology. Eur J Neurol. 2022;29(9):2832&#x2010;2841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno&#x2010;P&#xe9;rez O, Merino E, Leon&#x2010;Ramirez JM, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2010;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>
Petek BJ, Moulson N, Baggish AL, et al. Prevalence and clinical implications of persistent or exertional cardiopulmonary symptoms following SARS&#x2010;CoV&#x2010;2 infection in 3597 collegiate athletes: a study from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA). Br J Sports Med. 2021;56(16):913&#x2010;918. http://www.ncbi.nlm.nih.gov/pubmed/34725052. Accessed February 2, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8561826</ArticleId><ArticleId IdType="pubmed">34725052</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez&#x2010;Pastora J, Weigand M, Kim J, et al. Hyperferritinemia in critically ill COVID&#x2010;19 patients&#x2014;is ferritin the product of inflammation or a pathogenic mediator? Clin Chim Acta. 2020;509:249&#x2010;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306200</ArticleId><ArticleId IdType="pubmed">32579952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Levine BD, Phelan D, et al. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2020;6(2):219&#x2010;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">33104154</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggish AL, Ackerman MJ, Lampert R. Competitive sport participation among athletes with heart disease: a call for a paradigm shift in decision making. Circulation. 2017;136(17):1569&#x2010;1571.</Citation><ArticleIdList><ArticleId IdType="pubmed">29061571</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>